Smart Mary H, Lin Janet Y, Layden Brian T, Eisenberg Yuval, Pickard A Simon, Sharp Lisa K, Danielson Kirstie K, Kong Angela
Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, The University of Illinois Chicago, Chicago, Illinois, USA.
Department of Emergency Medicine, College of Medicine, The University of Illinois Chicago, Chicago, Illinois, USA.
J Diabetes Res. 2025 Mar 12;2025:8830658. doi: 10.1155/jdr/8830658. eCollection 2025.
We developed a prediction model for elevated hemoglobin A1c (HbA1c) among patients presenting to the emergency department (ED) at risk for diabetes to identify important factors that may influence follow-up patient care. Retrospective electronic health records data among patients screened for diabetes at the ED in May 2021 was used. The primary outcome was elevated HbA1c (≥ 5.7%). The data was divided into a derivation set (80%) and a test set (20%) stratified by elevated HbA1c. In the derivation set, we estimated the optimal significance level for backward elimination using a 10-fold cross-validation method. A final model was derived using the entire derivation set and validated on the test set. Performance statistics included C-statistic, sensitivity, specificity, predictive values, Hosmer-Lemeshow test, and Brier score. There were 590 ED patients screened for diabetes in May 2021. The final model included nine variables: age, race/ethnicity, insurance, chief complaints of back pain and fever/chills, and a past medical history of obesity, hyperlipidemia, chronic obstructive pulmonary disease, and substance misuse. Adequate model discrimination (C-statistic = 0.75; sensitivity, specificity, and predictive values > 0.70), no evidence of model ill fit (Hosmer-Lemeshow test = 0.29), and moderate Brier score (0.21) suggest acceptable model performance. In addition to age, obesity, and hyperlipidemia, a history of substance misuse was identified as an important predictor of elevated HbA1c levels among patients screened for diabetes in the ED. Our findings suggest that substance misuse may be an important factor to consider when facilitating follow-up care for patients identified with prediabetes or diabetes in the ED and warrants further investigation. Future research efforts should also include external validation in larger samples of ED patients.
我们为前往急诊科(ED)且有糖尿病风险的患者开发了一种预测糖化血红蛋白(HbA1c)升高的模型,以识别可能影响患者后续护理的重要因素。我们使用了2021年5月在急诊科接受糖尿病筛查的患者的回顾性电子健康记录数据。主要结局是HbA1c升高(≥5.7%)。数据按HbA1c升高情况分层分为一个推导集(80%)和一个测试集(20%)。在推导集中,我们使用10折交叉验证法估计向后消除的最佳显著性水平。使用整个推导集得出最终模型,并在测试集上进行验证。性能统计包括C统计量、敏感性、特异性、预测值、Hosmer-Lemeshow检验和Brier评分。2021年5月有590名急诊科患者接受了糖尿病筛查。最终模型包括九个变量:年龄、种族/民族、保险、背痛和发热/寒战的主要投诉,以及肥胖、高脂血症、慢性阻塞性肺疾病和药物滥用的既往病史。模型具有足够的区分度(C统计量 = 0.75;敏感性、特异性和预测值 > 0.70),没有模型拟合不佳的证据(Hosmer-Lemeshow检验 = 0.29),且Brier评分适中(0.21),表明模型性能可接受。除年龄、肥胖和高脂血症外,药物滥用史被确定为急诊科接受糖尿病筛查患者HbA1c水平升高的重要预测因素。我们的研究结果表明,在为急诊科确诊为糖尿病前期或糖尿病的患者提供后续护理时,药物滥用可能是一个需要考虑的重要因素,值得进一步研究。未来的研究工作还应包括在更大样本的急诊科患者中进行外部验证。